Sanofi ADR (SNYN)

Mexico


Symbol	Exchange	Currency
SNY	NASDAQ	USD	Real-time
SANp	BATS Europe	EUR	Delayed
0O59	London	EUR	Real-time
SNYN	Mexico	MXN	Delayed
SANF	Milan	EUR	Real-time
SASY	Xetra	EUR	Delayed
SASY	Frankfurt	EUR	Delayed
SASY	TradeGate	EUR	Delayed
SNYy	TradeGate	EUR	Delayed
SASY	Paris	EUR	Real-time
SASY	Vienna	EUR	Real-time

Currency in MXN

Disclaimer

1,100.00

0.00(0.00%)

Closed01/10

Fair Value

Unlock Value

Day's Range

1,100.00

52 wk Range

718.84

1,149.00

SNYN Income Statement

Featured here, the Income Statement (earnings report) for Sanofi ADR, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

aa.aa

37,631

37,369

39,175

45,389

46,033

Total Revenues Growth

aa.aa

+5.48%

-0.7%

+4.83%

+15.86%

+1.42%

Cost Of Revenues

aa.aa

11,976

12,106

12,251

13,692

14,216

Gross Profit

aa.aa

25,655

25,263

26,924

31,697

31,817

Gross Profit Growth

aa.aa

+5.33%

-1.53%

+6.57%

+17.73%

+0.38%

Gross Profit Margin %

aa.aa

68.18%

67.6%

68.73%

69.83%

69.12%

Other Operating Expenses, Total

aa.aa

18,853

17,684

18,359

20,659

22,615

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+2.84%	-6.2%	+3.82%	+12.53%	+9.47%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	6,020	5,530	5,692	6,706	6,728
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	9,967	9,448	9,599	10,539	10,765
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	720	1,025	1,488	1,587	2,950

Operating Income

aa.aa

6,802

7,579

8,565

11,038

9,202

Operating Income Growth

aa.aa

+12.92%

+11.42%

+13.01%

+28.87%

-16.63%

EBIT Margin %

aa.aa

18.08%

20.28%

21.86%

24.32%

19.99%

Net Interest Expenses

aa.aa

-453

-422

-359

-221

Net Interest Expenses Growth

aa.aa

-13.53%

+6.84%

+14.93%

+38.44%

+108.6%

Interest Expense, Total

aa.aa

-544

-459

-362

-394

-527

Interest And Investment Income

aa.aa

173

546

Other Non Operating Expenses, Total

aa.aa

492

497

111

101

-782

EBT, Excl. Unusual Items

aa.aa

6,841

7,654

8,317

10,918

8,439

Gain (Loss) On Sale Of Assets

aa.aa

296

443

418

655

688

Other Unusual Items, Total

aa.aa

-3,039

-206

-77

255

-578

EBT, Incl. Unusual Items

aa.aa

3,007

14,137

7,837

10,490

7,038

EBT, Incl. Unusual Items Growth

aa.aa

-38.68%

+370.14%

-44.56%

+33.85%

-32.91%

EBT, Incl. Unusual Items Margin

aa.aa

7.99%

37.83%

20.01%

23.11%

15.29%

Income Tax Expense

aa.aa

121

1,807

1,558

2,006

1,602

Net Income to Company

aa.aa

2,785

12,330

6,279

8,484

5,436

Minority Interest

aa.aa

-31

-36

-56

-113

-36

Net Income

aa.aa

2,754

12,294

6,223

8,371

5,400

Net Income Growth

aa.aa

-36.04%

+346.41%

-49.38%

+34.52%

-35.49%

Net Income Margin %

aa.aa

7.32%

32.9%

15.89%

18.44%

11.73%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

2,855

12,294

6,223

8,371

5,400

Basic EPS - Continuing Operations

aa.aa

2.28

9.81

4.97

6.69

4.31

Basic EPS - Continuing Operations Growth

aa.aa

-34.04%

+329.34%

-49.34%

+34.58%

-35.48%

Diluted EPS - Continuing Operations

aa.aa

2.27

9.76

4.95

6.66

4.3

Diluted EPS - Continuing Operations Growth

aa.aa

-34.01%

+329.96%

-49.28%

+34.55%

-35.44%

Basic Weighted Average Shares Outstanding

aa.aa

1,249.9

1,253.6

1,252.5

1,251.9

1,251.7

Diluted Weighted Average Shares Outstanding

aa.aa

1,257.1

1,260.1

1,257.9

1,256.9

1,256.4

Dividend Per Share

aa.aa

3.15

3.2

3.33

3.56

3.76

Dividend Per Share Growth

aa.aa

+2.61%

+1.59%

+4.06%

+6.91%

+5.62%

EBITDA

aa.aa

10,113

10,466

11,251

14,062

12,520

EBITDA Growth

aa.aa

+8.01%

+3.49%

+7.5%

+24.98%

-10.97%

EBITDA Margin %

aa.aa

26.87%

28.01%

28.72%

30.98%

27.2%

EBIT

aa.aa

Popular Searches

Please try another search

Sanofi ADR (SNYN)

SNYN Income Statement